Evaluation of the Triage PPY On-Site Testing Device for the Detection of Dextropropoxyphene in Urine
A new point-of-care colloidal metal immunoassay urine drugs-of-abuse testing device, the BIOSITE TRIAGE® Plus Propoxyphene (TPP), was evaluated for the rapid detection of dextropropoxyphene (PPY) and/or its primary metabolite, norpropoxyphene (NP), in urine at a total PPY/NP concentration of 300 ng/...
Gespeichert in:
| Veröffentlicht in: | Journal of analytical toxicology 2004-09, Vol.28 (6), p.485-488 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 488 |
|---|---|
| container_issue | 6 |
| container_start_page | 485 |
| container_title | Journal of analytical toxicology |
| container_volume | 28 |
| creator | Poklis, Alphonse Poklis, Justin L. Tarna, Lisa D. Backer, Ronald C. |
| description | A new point-of-care colloidal metal immunoassay urine drugs-of-abuse testing device, the BIOSITE TRIAGE® Plus Propoxyphene (TPP), was evaluated for the rapid detection of dextropropoxyphene (PPY) and/or its primary metabolite, norpropoxyphene (NP), in urine at a total PPY/NP concentration of 300 ng/mL or greater. This assay has been added to the Triage device that tests for commonly abused drugs. Adding to drug-free urine PPY and NP established the linearity of the TPP assay at concentrations of 40%, 80%, 120%, and 160% of the cut-off concentration. No significant cross-reactivity was found at 1.0 g/L for 32 drugs commonly encountered in emergency department admissions. Significant cross-reactivity was observed only with diphenhydramine and tricyclic antidepressants. TPP results from 160 urine specimens screened for PPY and/or NP were compared to those obtained by testing with DRI® enzyme immunoassay, Emit II plus immunoassay, Abuscreen® Online immunoassay and gas chromatography-mass spectrometry (GC-MS). There was a 98.8% agreement of positive or negative results between TPP and both the DRI and OnLine assays. The two discordant TPP results were due to concentrations of NP below the TPP minimum cross-reactivity value of 400 ng/mL. These two specimens yielded GC-MS NP concentrations of 262 and 359 ng/mL. These NP concentrations were within ± 20% of the cross-reactivity cut-off value for NP for TPP, DRI, and Online. There was only an 88% agreement of positive or negative results between TPP and the Emit assay. Twenty urine specimens yielding PPY positive results when tested by TPP were negative by Emit testing. The discordant TPP results were due to poor cross-reactivity of Emit to NP. A 98.8% agreement of positive PPY results was observed between TPP and GC-MS. Discordant urines were found to contain PPY concentrations below the cut-off value of the assay. TPP was found to be an accurate device for the detection of PPY and NP in urine. |
| doi_str_mv | 10.1093/jat/28.6.485 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67031257</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jat/28.6.485</oup_id><sourcerecordid>67031257</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-cd678cb0adc8eb1b40592b89164b44af93bffe47f7f76a3e6ae4d3aa7a9fecd73</originalsourceid><addsrcrecordid>eNqF0E1v1DAQBmALgehSuHFGvgAXsrXjjyRH6LYUqVKL2groxZo449Ylmyy2U23_PV52oUdkS5asxzPjl5DXnM05a8TBHaSDsp7ruazVEzLjjVRFKZl4SmaMS13ISrM98iLGO8a4rrV4Tva4UlwLxmakO7qHfoLkx4GOjqZbpJfBww3S8_Mf9GwoLnzKVxiTH27oAu-9RerG8EcuMKH9-3SB6xTGVd7j-mF1iwNSP9Cr4Ad8SZ456CO-2p375Or46PLwpDg9-_zl8ONpYUVdpcJ2uqpty6CzNba8lUw1ZVs3XMtWSnCNaJ1DWbm8NAjUgLITABU0Dm1XiX3ybls3T_FryjObpY8W-x4GHKdodMUEL9UGfthCG8YYAzqzCn4J4cFwZjapmpyqKWujTU418ze7ulO7xO4R72LM4O0OQLTQuwCD9fHRadZo3mwKvd-6cVr9r2WxlT4mXP-zEH7mX4hKmZPv10ZdfxXfLo4_GSV-AyBBnSw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67031257</pqid></control><display><type>article</type><title>Evaluation of the Triage PPY On-Site Testing Device for the Detection of Dextropropoxyphene in Urine</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Poklis, Alphonse ; Poklis, Justin L. ; Tarna, Lisa D. ; Backer, Ronald C.</creator><creatorcontrib>Poklis, Alphonse ; Poklis, Justin L. ; Tarna, Lisa D. ; Backer, Ronald C.</creatorcontrib><description>A new point-of-care colloidal metal immunoassay urine drugs-of-abuse testing device, the BIOSITE TRIAGE® Plus Propoxyphene (TPP), was evaluated for the rapid detection of dextropropoxyphene (PPY) and/or its primary metabolite, norpropoxyphene (NP), in urine at a total PPY/NP concentration of 300 ng/mL or greater. This assay has been added to the Triage device that tests for commonly abused drugs. Adding to drug-free urine PPY and NP established the linearity of the TPP assay at concentrations of 40%, 80%, 120%, and 160% of the cut-off concentration. No significant cross-reactivity was found at 1.0 g/L for 32 drugs commonly encountered in emergency department admissions. Significant cross-reactivity was observed only with diphenhydramine and tricyclic antidepressants. TPP results from 160 urine specimens screened for PPY and/or NP were compared to those obtained by testing with DRI® enzyme immunoassay, Emit II plus immunoassay, Abuscreen® Online immunoassay and gas chromatography-mass spectrometry (GC-MS). There was a 98.8% agreement of positive or negative results between TPP and both the DRI and OnLine assays. The two discordant TPP results were due to concentrations of NP below the TPP minimum cross-reactivity value of 400 ng/mL. These two specimens yielded GC-MS NP concentrations of 262 and 359 ng/mL. These NP concentrations were within ± 20% of the cross-reactivity cut-off value for NP for TPP, DRI, and Online. There was only an 88% agreement of positive or negative results between TPP and the Emit assay. Twenty urine specimens yielding PPY positive results when tested by TPP were negative by Emit testing. The discordant TPP results were due to poor cross-reactivity of Emit to NP. A 98.8% agreement of positive PPY results was observed between TPP and GC-MS. Discordant urines were found to contain PPY concentrations below the cut-off value of the assay. TPP was found to be an accurate device for the detection of PPY and NP in urine.</description><identifier>ISSN: 0146-4760</identifier><identifier>EISSN: 1945-2403</identifier><identifier>DOI: 10.1093/jat/28.6.485</identifier><identifier>PMID: 15516300</identifier><identifier>CODEN: JATOD3</identifier><language>eng</language><publisher>Niles, IL: Oxford University Press</publisher><subject>Analgesics, Opioid - urine ; Analysis ; Antibodies - analysis ; Biological and medical sciences ; Cross Reactions ; Dextropropoxyphene - analogs & derivatives ; Dextropropoxyphene - urine ; False Positive Reactions ; Gas Chromatography-Mass Spectrometry ; General pharmacology ; Humans ; Immunoassay ; Indicators and Reagents ; Medical sciences ; Online Systems ; Pharmacology. Drug treatments ; Point-of-Care Systems ; Reproducibility of Results ; Street Drugs - urine ; Substance Abuse Detection - instrumentation</subject><ispartof>Journal of analytical toxicology, 2004-09, Vol.28 (6), p.485-488</ispartof><rights>2004</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-cd678cb0adc8eb1b40592b89164b44af93bffe47f7f76a3e6ae4d3aa7a9fecd73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,1584,23930,23931,25140,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16096195$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15516300$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Poklis, Alphonse</creatorcontrib><creatorcontrib>Poklis, Justin L.</creatorcontrib><creatorcontrib>Tarna, Lisa D.</creatorcontrib><creatorcontrib>Backer, Ronald C.</creatorcontrib><title>Evaluation of the Triage PPY On-Site Testing Device for the Detection of Dextropropoxyphene in Urine</title><title>Journal of analytical toxicology</title><addtitle>Journal of Analytical Toxicology</addtitle><addtitle>Journal of Analytical Toxicology</addtitle><description>A new point-of-care colloidal metal immunoassay urine drugs-of-abuse testing device, the BIOSITE TRIAGE® Plus Propoxyphene (TPP), was evaluated for the rapid detection of dextropropoxyphene (PPY) and/or its primary metabolite, norpropoxyphene (NP), in urine at a total PPY/NP concentration of 300 ng/mL or greater. This assay has been added to the Triage device that tests for commonly abused drugs. Adding to drug-free urine PPY and NP established the linearity of the TPP assay at concentrations of 40%, 80%, 120%, and 160% of the cut-off concentration. No significant cross-reactivity was found at 1.0 g/L for 32 drugs commonly encountered in emergency department admissions. Significant cross-reactivity was observed only with diphenhydramine and tricyclic antidepressants. TPP results from 160 urine specimens screened for PPY and/or NP were compared to those obtained by testing with DRI® enzyme immunoassay, Emit II plus immunoassay, Abuscreen® Online immunoassay and gas chromatography-mass spectrometry (GC-MS). There was a 98.8% agreement of positive or negative results between TPP and both the DRI and OnLine assays. The two discordant TPP results were due to concentrations of NP below the TPP minimum cross-reactivity value of 400 ng/mL. These two specimens yielded GC-MS NP concentrations of 262 and 359 ng/mL. These NP concentrations were within ± 20% of the cross-reactivity cut-off value for NP for TPP, DRI, and Online. There was only an 88% agreement of positive or negative results between TPP and the Emit assay. Twenty urine specimens yielding PPY positive results when tested by TPP were negative by Emit testing. The discordant TPP results were due to poor cross-reactivity of Emit to NP. A 98.8% agreement of positive PPY results was observed between TPP and GC-MS. Discordant urines were found to contain PPY concentrations below the cut-off value of the assay. TPP was found to be an accurate device for the detection of PPY and NP in urine.</description><subject>Analgesics, Opioid - urine</subject><subject>Analysis</subject><subject>Antibodies - analysis</subject><subject>Biological and medical sciences</subject><subject>Cross Reactions</subject><subject>Dextropropoxyphene - analogs & derivatives</subject><subject>Dextropropoxyphene - urine</subject><subject>False Positive Reactions</subject><subject>Gas Chromatography-Mass Spectrometry</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Immunoassay</subject><subject>Indicators and Reagents</subject><subject>Medical sciences</subject><subject>Online Systems</subject><subject>Pharmacology. Drug treatments</subject><subject>Point-of-Care Systems</subject><subject>Reproducibility of Results</subject><subject>Street Drugs - urine</subject><subject>Substance Abuse Detection - instrumentation</subject><issn>0146-4760</issn><issn>1945-2403</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0E1v1DAQBmALgehSuHFGvgAXsrXjjyRH6LYUqVKL2groxZo449Ylmyy2U23_PV52oUdkS5asxzPjl5DXnM05a8TBHaSDsp7ruazVEzLjjVRFKZl4SmaMS13ISrM98iLGO8a4rrV4Tva4UlwLxmakO7qHfoLkx4GOjqZbpJfBww3S8_Mf9GwoLnzKVxiTH27oAu-9RerG8EcuMKH9-3SB6xTGVd7j-mF1iwNSP9Cr4Ad8SZ456CO-2p375Or46PLwpDg9-_zl8ONpYUVdpcJ2uqpty6CzNba8lUw1ZVs3XMtWSnCNaJ1DWbm8NAjUgLITABU0Dm1XiX3ybls3T_FryjObpY8W-x4GHKdodMUEL9UGfthCG8YYAzqzCn4J4cFwZjapmpyqKWujTU418ze7ulO7xO4R72LM4O0OQLTQuwCD9fHRadZo3mwKvd-6cVr9r2WxlT4mXP-zEH7mX4hKmZPv10ZdfxXfLo4_GSV-AyBBnSw</recordid><startdate>20040901</startdate><enddate>20040901</enddate><creator>Poklis, Alphonse</creator><creator>Poklis, Justin L.</creator><creator>Tarna, Lisa D.</creator><creator>Backer, Ronald C.</creator><general>Oxford University Press</general><general>Preston</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040901</creationdate><title>Evaluation of the Triage PPY On-Site Testing Device for the Detection of Dextropropoxyphene in Urine</title><author>Poklis, Alphonse ; Poklis, Justin L. ; Tarna, Lisa D. ; Backer, Ronald C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-cd678cb0adc8eb1b40592b89164b44af93bffe47f7f76a3e6ae4d3aa7a9fecd73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Analgesics, Opioid - urine</topic><topic>Analysis</topic><topic>Antibodies - analysis</topic><topic>Biological and medical sciences</topic><topic>Cross Reactions</topic><topic>Dextropropoxyphene - analogs & derivatives</topic><topic>Dextropropoxyphene - urine</topic><topic>False Positive Reactions</topic><topic>Gas Chromatography-Mass Spectrometry</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Immunoassay</topic><topic>Indicators and Reagents</topic><topic>Medical sciences</topic><topic>Online Systems</topic><topic>Pharmacology. Drug treatments</topic><topic>Point-of-Care Systems</topic><topic>Reproducibility of Results</topic><topic>Street Drugs - urine</topic><topic>Substance Abuse Detection - instrumentation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poklis, Alphonse</creatorcontrib><creatorcontrib>Poklis, Justin L.</creatorcontrib><creatorcontrib>Tarna, Lisa D.</creatorcontrib><creatorcontrib>Backer, Ronald C.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of analytical toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poklis, Alphonse</au><au>Poklis, Justin L.</au><au>Tarna, Lisa D.</au><au>Backer, Ronald C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the Triage PPY On-Site Testing Device for the Detection of Dextropropoxyphene in Urine</atitle><jtitle>Journal of analytical toxicology</jtitle><stitle>Journal of Analytical Toxicology</stitle><addtitle>Journal of Analytical Toxicology</addtitle><date>2004-09-01</date><risdate>2004</risdate><volume>28</volume><issue>6</issue><spage>485</spage><epage>488</epage><pages>485-488</pages><issn>0146-4760</issn><eissn>1945-2403</eissn><coden>JATOD3</coden><abstract>A new point-of-care colloidal metal immunoassay urine drugs-of-abuse testing device, the BIOSITE TRIAGE® Plus Propoxyphene (TPP), was evaluated for the rapid detection of dextropropoxyphene (PPY) and/or its primary metabolite, norpropoxyphene (NP), in urine at a total PPY/NP concentration of 300 ng/mL or greater. This assay has been added to the Triage device that tests for commonly abused drugs. Adding to drug-free urine PPY and NP established the linearity of the TPP assay at concentrations of 40%, 80%, 120%, and 160% of the cut-off concentration. No significant cross-reactivity was found at 1.0 g/L for 32 drugs commonly encountered in emergency department admissions. Significant cross-reactivity was observed only with diphenhydramine and tricyclic antidepressants. TPP results from 160 urine specimens screened for PPY and/or NP were compared to those obtained by testing with DRI® enzyme immunoassay, Emit II plus immunoassay, Abuscreen® Online immunoassay and gas chromatography-mass spectrometry (GC-MS). There was a 98.8% agreement of positive or negative results between TPP and both the DRI and OnLine assays. The two discordant TPP results were due to concentrations of NP below the TPP minimum cross-reactivity value of 400 ng/mL. These two specimens yielded GC-MS NP concentrations of 262 and 359 ng/mL. These NP concentrations were within ± 20% of the cross-reactivity cut-off value for NP for TPP, DRI, and Online. There was only an 88% agreement of positive or negative results between TPP and the Emit assay. Twenty urine specimens yielding PPY positive results when tested by TPP were negative by Emit testing. The discordant TPP results were due to poor cross-reactivity of Emit to NP. A 98.8% agreement of positive PPY results was observed between TPP and GC-MS. Discordant urines were found to contain PPY concentrations below the cut-off value of the assay. TPP was found to be an accurate device for the detection of PPY and NP in urine.</abstract><cop>Niles, IL</cop><pub>Oxford University Press</pub><pmid>15516300</pmid><doi>10.1093/jat/28.6.485</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0146-4760 |
| ispartof | Journal of analytical toxicology, 2004-09, Vol.28 (6), p.485-488 |
| issn | 0146-4760 1945-2403 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67031257 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Analgesics, Opioid - urine Analysis Antibodies - analysis Biological and medical sciences Cross Reactions Dextropropoxyphene - analogs & derivatives Dextropropoxyphene - urine False Positive Reactions Gas Chromatography-Mass Spectrometry General pharmacology Humans Immunoassay Indicators and Reagents Medical sciences Online Systems Pharmacology. Drug treatments Point-of-Care Systems Reproducibility of Results Street Drugs - urine Substance Abuse Detection - instrumentation |
| title | Evaluation of the Triage PPY On-Site Testing Device for the Detection of Dextropropoxyphene in Urine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T06%3A26%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20Triage%20PPY%20On-Site%20Testing%20Device%20for%20the%20Detection%20of%20Dextropropoxyphene%20in%20Urine&rft.jtitle=Journal%20of%20analytical%20toxicology&rft.au=Poklis,%20Alphonse&rft.date=2004-09-01&rft.volume=28&rft.issue=6&rft.spage=485&rft.epage=488&rft.pages=485-488&rft.issn=0146-4760&rft.eissn=1945-2403&rft.coden=JATOD3&rft_id=info:doi/10.1093/jat/28.6.485&rft_dat=%3Cproquest_cross%3E67031257%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67031257&rft_id=info:pmid/15516300&rft_oup_id=10.1093/jat/28.6.485&rfr_iscdi=true |